Product Description
Zila, Inc, a leading oral cancer diagnostic company focused on the prevention and treatment of oral diseases,
announced that ViziLite Plus with TBlue630, the emerging standard of care for the early detection of oral
abnormalities that could lead to cancer, now includes Pearlescent retractors, replacing the earlier transparent
devices. Featuring an opaque backside, the new retractors focus more light on the oral cavity and block light
from shining directly back at the clinician.
|
|
Request More Info
|